Market Place
Sourcing Support
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
06 Jan 2018 //
FIERCE PHARMA
Sanofi introduces new Priftin packaging to treat latent tuberculosis
03 Dec 2015 //
PR NEWS WIRE
AbbVie Demonstrate Commitment to Hep C Patients with New Data on VIEKIRA PAK™
01 Oct 2015 //
PR NEWSWIRE
AbbVie`s VIEKIRAX Receives Approval in Japan for Chronic Hepatitis C
28 Sep 2015 //
PR NEWS WIRE
NHS England stumps up £190m for hep C therapy
12 Jun 2015 //
PHARMATIMES
Hep C landscape shifts again as BMS combo nabs breakthrough tag
20 May 2015 //
FIERCE PHARMA
Ranks of `super-spender` patients triple, pushing drug bills up $52B
13 May 2015 //
FIERCE PHARMA
Gilead ready to take the cash from hep C superstars and buy something
01 May 2015 //
FIERCE PHARMA
AbbVie says disappointing Viekira sales numbers are misleading
28 Apr 2015 //
FIERCE PHARMA MARKETING
AbbVie moves closer to Japan`s crowded hep C field with priority review nod
17 Apr 2015 //
FIERCE PHARMA
Medicaid Drug-Spending Hikes Rile Lawmakers, But There`s No End In Sight
13 Apr 2015 //
FIERCE PHARMA
Gilead’s $1,000 Pill Is Hard for States to Swallow
10 Apr 2015 //
THE WALL STREET JOURNAL
Watch out for a two-front hep C price war when Merck`s combo hits
09 Apr 2015 //
FIERCE PHARMA
Heavyweight PBMs Mean Trouble For Big Pharma`s Pricey New Meds
31 Mar 2015 //
FIERCE PHARMA
Gilead Warning of Hep C Patient Death on Heart Med Will Have “Zero Impact”
24 Mar 2015 //
PHARMALOT
FDA Continues to Lead in Precision Medicine
23 Mar 2015 //
FDA VOICE
Thomson Reuters Names Most Promising Drugs of 2015
23 Mar 2015 //
THOMSON REUTERS
Big Pharma`s market cap stars of 2014: Lilly, AbbVie, AstraZeneca
19 Mar 2015 //
FIERCE PHARMA
Drug spending surged 13% last year, with pricey hep C meds leading the charge
10 Mar 2015 //
FIERCE PHARMA
Bristol Hep C Drug Helps Cure 97 pct of HIV Coinfected Patients-Study
28 Feb 2015 //
REUTERS
Gilead Looks Overseas to Guard Sovaldi Profits from Taxes
27 Feb 2015 //
FIERCE PHARMA
Crown the New Drug Launch King: Gilead`s Harvoni Has Knocked Aside Sister Med Sovaldi
18 Feb 2015 //
FIERCE PHARMA MARKETING
Say What? CVS Health Execs Figure PCSK9 Meds to Cost up to $150B
17 Feb 2015 //
FIERCE PHARMA
Gilead Expects Big Increase in Europeans Treated with Hep C Drug
16 Feb 2015 //
REUTERS
Gilead`s Pricey Sovaldi Lost a Patent in India. Now, Its EU Patent is Under Siege
16 Feb 2015 //
FIERCE PHARMA
Humira Biosimilars Will Gut Abbvie`s Sales in 3 Years, Analyst Says
16 Feb 2015 //
FIERCE PHARMA
Abbvie`s Exviera (Dasabuvir) Approved in Europe for Hepatitis C
12 Feb 2015 //
EMA
